(MENAFN- Baystreet) 09:38 AM EST - Doseology Sciences Inc: Announces its wholly owned Florida subsidiary, Doseology USA Inc., has executed a confidential manufacturing agreement with a leading North American production partner.“This is much more than a manufacturing agreement, it's a defining moment as it enables Doseology to move from R&D to commercial deployment,” said Tim Corkum, President & COO of Doseology.“Through Doseology USA Inc., we've secured an American partner that delivers the scale, quality, and integrity we require as we prepare to enter the oral stimulant pouch market.” Doseology Sciences Inc shares C are trading unchanged at $0.35.

Full Press Release:

MENAFN13112025000212011056ID1110339979